bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
Q4 2025 vs. Q3 2025
How the institutions holding bioAffinity Technologies, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 12 | 9 | −3 |
| Shares | 301.9K | 78.4K | −223.4K (−74.0%) |
| Value | $823.7K | $92.5K | −$731.2K (−88.8%) |
New holders (4)
Institutions that held bioAffinity Technologies, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 30,422 | $35.9K | 0.00% |
| Northern Trust Corp | 12,725 | $15.0K | 0.00% |
| Citadel Advisors LLC | 11,631 | $13.7K | 0.00% |
| Two Sigma Securities, LLC | 11,125 | $13.1K | 0.00% |
Sold out (7)
Institutions that held bioAffinity Technologies, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Sabby Management, LLC | 242,757 | $718.6K |
| Scientech Research LLC | 16,583 | $49.1K |
| Vanguard Group Inc | 10,429 | $30.9K |
| Allworth Financial LP | 1,791 | $5.30K |
| UBS Group AG | 143 | $423 |
| Larson Financial Group LLC | 33 | $98 |
| FMR LLC | 26 | $77 |